Nearly 1,000 people participated in Colorectal Cancer Awareness Month activities on Wednesday, March 2, at The Mount Sinai Hospital. Visitors picked up educational literature and giveaways, and walked through a 30-ft. inflatable model of a colon, known as the “Rollin’ Colon”—provided by the Colon Cancer Challenge Foundation—that exhibits polyps and other signs of colon cancer. They also had the opportunity to talk with nurses, physicians, geneticists, nutritionists, and endoscopy staff. Forty seven attendees signed up for a screening colonoscopy. The event was hosted by The Mount Sinai Hospital Endoscopy Center.
Research into a novel treatment that could help extend the lives of patients with multiple myeloma—a disease in which cancerous blood cells proliferate in the bone marrow—is being advanced by scientists at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, who recently identified a new drug target called ARK5.
The Mount Sinai scientists discovered that when ARK5 is targeted simultaneously with CDK4, a pathway widely known to have a role in inhibiting multiple myeloma, the results were extremely effective in causing cell death. Their findings were published in the March 15, 2016, issue of the journal Cancer Research. Read more
The upbeat dance-pop song “Feel This Moment” was playing at full volume in the Annenberg West lobby on Friday, March 18, as graduating medical students opened their envelopes to learn which residency programs they would be attending during the next phase of their training. Joining them were family members, friends, and Mount Sinai Health System physicians and staff who shared in their energy and excitement, and offered hugs and congratulations during the annual Match Day event.
The Icahn School of Medicine at Mount Sinai’s graduating students were matched to residency programs throughout the country, including highly competitive ones at Brigham and Women’s Hospital, Hospital of the University of Pennsylvania, Yale-New Haven Hospital, Duke University Medical Center, and University of California San Francisco Medical Center. Fifty one students will remain within the Mount Sinai Health System to continue all or part of their graduate training. Read more
A new knowledge and data-sharing platform created by researchers at the Mount Sinai Health System is designed to help physicians weed through the thousands of mobile health apps that enter the market each year and identify the ones that successfully improve patient health. Called NODE Health (Network of Digital Evidence in Health), the platform was created by researchers at Mount Sinai’s AppLab, which is led by Ashish Atreja, MD, MPH, Chief Technology Innovation and Engagement Officer in the Department of Medicine, and Assistant Professor of Medicine (Gastroenterology). NODEHealth.org will provide physicians and other health care providers with an evidence-based review process and data-sharing network that is similar to ClinicalTrials.gov, enabling them to compare studies from around the world to find the health care apps that work best for their specialized needs. Read more
Research under way at the Icahn School of Medicine at Mount Sinai is revolutionizing the management of type 1 diabetes by using novel technology that serves as an artificial pancreas and automatically enables patients to achieve more stable glucose levels 24 hours a day.
Led by Carol Levy, MD, Associate Professor of Medicine (Endocrinology, Diabetes and Bone Disease), the Icahn School of Medicine is one of nine U.S. and European sites participating in the research, and sharing a $12.7 million grant from the National Institutes of Health. Dr. Levy is one of the study’s lead investigators. Read more
Catherine Roosevelt is a vibrant 30-year-old woman who is dedicated both to her career as the Advancement Director for a nonprofit organization serving girls living in poverty and to her numerous volunteer commitments. In a typical year, she travels an average of one weekend a month for work or volunteer service and spends a month every summer in Lake Placid, New York, co-directing a summer camp. Combined with a busy social life, her days and evenings can be stressful and tiring, but maintaining an active schedule validates a promise she made to herself six years ago, when she was diagnosed with multiple sclerosis (MS): “I won’t let my disease define me.” Read more
Researchers at Mount Sinai’s Corinne Goldsmith Dickinson Center for Multiple Sclerosis played a key role in developing a potential breakthrough treatment for progressive multiple sclerosis (MS), according to findings that were presented in October 2015 at the meeting of the European Committee for Treatment and Research in MS in Barcelona, Spain. The Center also recently received funding to lead a new international coalition tasked with developing a strategy for diagnosing progressive MS earlier. Both efforts further strengthen Mount Sinai’s reputation as a worldwide leader in MS research. Read more
During Black History Month in February, the Icahn School of Medicine at Mount Sinai honored its first black male deans, Gary C. Butts, MD, and Reginald Miller, DVM, for their significant contributions to the institution.
Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System, spoke at the Honorary Deans’ Reception that was hosted by Mount Sinai’s Office for Diversity and Inclusion and Black Leaders Advocating for Change and Community, an employee resource group. Read more
More than 775 staff and visitors attended health fairs sponsored by Mount Sinai Heart on Friday, February 5, Go Red for Women Day®, an annual educational event that spotlights the risks of cardiovascular disease. Participants received free screenings for high blood pressure, cholesterol, weight, glucose, and peripheral vascular disease, and learned about nutrition and diet, diabetes, stress management, smoking cessation, and relaxation techniques. Other events included exercise workshops, support group meetings, and educational lectures sponsored by Women’s Heart NY, a comprehensive Mount Sinai Health System heart program.
Gary Rosenberg, PhD, the Edith J. Baerwald Professor of Preventive Medicine at the Icahn School of Medicine at Mount Sinai, received an award for 30 years of service as Chair of the Mount Sinai Community Advisory Board (CAB) when he retired from that position on Tuesday, February 23.
“Dr. Rosenberg has done a remarkable job chairing the CAB, forging strong connections to the community—particularly the residents of East Harlem—and ensuring that The Mount Sinai Hospital listens and responds to their health care needs and interests,” says John S. Winkleman, Trustee and Chair, Community Relations Committee, Mount Sinai Health System. David C. Thomas, MD, Professor of Medicine (Internal Medicine), Medical Education, and Rehabilitation Medicine, has been elected as the new Chair of the CAB, which was formed in 1979 as a Boards of Trustees committee.